Ligand validation:6ZLK

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 6ZLK designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6ZLK_NAD_A_401	98%	47%	0.063	0.984	0.93	1.13	3	4	5	0	100%	1
6ZLK_NAD_B_401	96%	49%	0.069	0.98	0.89	1.09	1	4	6	0	100%	1
6ZLK_NAD_D_401	96%	52%	0.068	0.977	0.8	1.07	1	2	5	0	100%	1
6ZLK_NAD_C_401	96%	49%	0.07	0.979	0.75	1.2	-	5	3	0	100%	1
6ZLD_NAD_B_801	99%	52%	0.054	0.985	0.87	1	1	2	1	0	100%	1
6ZL6_NAD_B_902	98%	54%	0.061	0.98	0.89	0.89	1	2	0	0	100%	1
6ZLJ_NAD_A_401	96%	53%	0.071	0.98	0.88	0.93	4	4	1	0	100%	1
6ZLL_NAD_C_402	93%	55%	0.086	0.983	0.77	0.95	2	2	2	0	100%	1
6ZLA_NAD_A_401	90%	54%	0.097	0.982	0.85	0.91	1	2	0	0	100%	1
4URF_NAD_A_1249	100%	45%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	25%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1
1HET_NAD_A_402	100%	11%	0.043	0.994	2.25	2.1	9	8	0	0	100%	0.9068
2JHF_NAD_B_403	100%	18%	0.04	0.99	2.08	1.62	11	5	2	0	100%	1
1HEU_NAD_B_402	100%	8%	0.043	0.993	2.5	2.41	13	11	0	0	100%	0.8886

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.